DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACIPHEX SPRINKLE
02 1AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
03 3CLORAZEPATE DIPOTASSIUM
04 6ESOMEPRAZOLE MAGNESIUM
05 2EXTENDED PHENYTOIN SODIUM
06 1EZALLOR SPRINKLE
07 1FELODIPINE
08 1LEVOTHYROXINE SODIUM
09 1MOEXIPRIL HYDROCHLORIDE
10 1MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
11 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
12 2NICORETTE
13 2NICORETTE (MINT)
14 4NICOTINE POLACRILEX
15 1OMEPRAZOLE
16 1OMEPRAZOLE MAGNESIUM
17 1PHENYTEK
18 1PHENYTOIN SODIUM
19 1PITAVASTATIN CALCIUM
20 1PRAVACHOL
21 3PRAVASTATIN SODIUM
22 8RABEPRAZOLE SODIUM
23 1RAMIPRIL
24 5ROSUVASTATIN CALCIUM
25 1TELMISARTAN AND HYDROCHLOROTHIAZIDE
26 2TRANXENE
27 1TRANXENE SD
01 317105
02 218612
03 119898
04 220066
05 240298
06 140732
07 171111
08 171858
09 175731
10 175757
11 176568
12 176822
13 176885
14 176911
15 178191
16 178697
17 178699
18 178878
19 178964
20 190416
21 1202150
22 1202170
23 1202376
24 1203367
25 1203636
26 1204169
27 1204179
28 1204206
29 1204237
30 1204309
31 1204736
32 1204833
33 1205606
34 1205761
35 1205932
36 1206296
37 1206434
38 1206465
39 1207068
40 1207265
41 1207616
42 1208644
43 1208647
44 1208850
45 1208898
46 1209339
47 1209869
48 1212399
49 1213859
01 51No
02 3Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Drug : ROSUVASTATIN CALCIUM
Dosage Form : TABLET; ORAL
Application Number : 206434
Country : US
Patented : No
Drug : PRAVASTATIN SODIUM
Dosage Form : TABLET; ORAL
Application Number : 207068
Country : US
Patented : No
Drug : LEVOTHYROXINE SODIUM
Dosage Form : TABLET; ORAL
Application Number : 212399
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Drug : MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form : TABLET; ORAL
Application Number : 202150
Country : US
Patented : No
Drug : MOEXIPRIL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 90416
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 76885
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
